Publications by authors named "Rupert Gale"

Claim this Profile
E
Efficacy of once-daily indacaterol relative to alternative bronchodilators in COPD: a patient-level mixed treatment comparison.
Shannon Cope, Gorana Capkun-Niggli, Rupert Gale, Cheryl Lassen, Roger Owen

Value Health· May 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Application of latent growth and growth mixture modeling to identify and characterize differential responders to treatment for COPD.
Donald E Stull, Ingela Wiklund, Rupert Gale, Gorana Capkun-Niggli, Katherine Houghton

Contemp Clin Trials· November 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-utility analysis of indacaterol in Germany: a once-daily maintenance bronchodilator for patients with COPD.
David Price, Alastair Gray, Rupert Gale, Yumi Asukai, Laura Mungapen

Respir Med· November 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative efficacy of indacaterol 150 μg and 300 μg versus fixed-dose combinations of formoterol + budesonide or salmeterol + fluticasone for the treatment of chronic obstructive pulmonary disease--a network meta-analysis.
Shannon Cope, Gorana Capkun-Niggli, Rupert Gale, José R Jardim, Jeroen P Jansen

Int J Chron Obstruct Pulmon Dis· October 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Profiling the effects of indacaterol on dyspnoea and health status in patients with COPD.
Paul W Jones, Donald A Mahler, Rupert Gale, Roger Owen, Benjamin Kramer

Respir Med· June 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Three-year dispensing patterns with long-acting inhaled drugs in COPD: a database analysis.
Fernie Penning-van Beest, Myrthe van Herk-Sukel, Rupert Gale, Jan-Willem Lammers, Ron Herings

Respir Med· February 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Costs of chemotherapy for indolent follicular non-Hodgkin's lymphoma in the UK: an observational study.
Julia Hutchinson, Adam Lloyd, Alastair Gray, Rupert Gale, Barry Hancock

Acta Haematol· February 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis